What we found on the web about Pollinex Quattro
EvaluatePharma - Pollinex Quattro - Worldwide - Overview
Preliminary Results for the Year Ended 30 June 2009 Allergy Therapeutics (September 21, 2009) European Patent Granted For MPL-Based Sublingual Vaccines
Seasonal Allergy Vaccine on the Horizon
In another Pollinex Quattro study, 70% of patients injected with Pollinex Quattro vaccine were desensitized to allergens, and 87.8% showed symptom improvement.
Pollinex Quattro Ragweed Allergy Vaccine Enters Last Stages of ...
Allergy Therapeutics, the makers of ragweed allergy vaccine Pollinex-R, are making headway with a new version of ragweed allergy vaccine called Pollinex Quattro Ragweed. This new ...
Allergy Therapeutics Ltd. Reports Pivotal Phase III Pollinex® Quattro ...
Allergy Therapeutics Ltd. Reports Pivotal Phase III Pollinex® Quattro Ragweed Study Meets Primary Efficacy Endpoint 9/22/2008 Allergy Therapeutics -- Allergy Therapeutics plc ...
Allergy Therapeutics - FierceBiotech
Allergy Therapeutics plc ("Allergy Therapeutics" or "the Company") Pivotal Phase III Pollinex® Quattro grass study meets primary efficacy endpoint Largest ever global study ...
Pivotal Phase III Pollinex Quattro Ragweed Study Meets Primary ...
First ever large scale allergy vaccine study showing proof of safety and efficacy in Ragweed patients Further confirmation of Pollinex Quattro safety and effica
EvaluatePharma - Pollinex Quattro Ragweed - Worldwide - Overview
Preliminary Results for the Year Ended 30 June 2009 Allergy Therapeutics (September 21, 2009) Immunotherapy Tablet Containing Recombinant Allergen of Birch Pollen: Positive ...
Analyst Research Report Snapshot
Allergy Therapeutics has filed Pollinex Quattro in Germany, putting it on track for approval by this time next year. This will allow more active marketing and better pricing and ...
The Safetyand Clinical Efficacy of Pollinex-Rand Pollinex Quattro ...
The Safetyand Clinical Efficacy of Pollinex-Rand Pollinex Quattro Ragweed Assessed in an Environmental Exposure Chamber ®® P. Patel, A.M. Salapatek, C. Shah, K. Fischervon We ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Pollinex Quattro

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Pollinex Quattro
In the know: Bloomsbury; Allergy Therapeutics; May Gurney
Times Online
Allergy, unchanged at 12¾p, is developing Pollinex Quattro, a hay-fever inoculation. There are hopes that a delay in approval in the United States may be resolved this year, which would make the company a bid target. Bet of the day The Bank...